You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202019619676
Dec 202017517562
Jan 2021777732
Feb 2021515114
Mar 2021777741
Apr 2021838320
May 2021686818
Jun 2021575719
Jul 2021555521
Aug 2021484812
Sep 2021515119
Oct 2021646433
Nov 2021767438
Dec 2021656619
Jan 2022434610
Feb 2022232817
Mar 2022626627
Apr 2022475221
May 2022434415
Jun 2022485114
Jul 2022344213
Aug 2022666618
Sep 2022535319
Oct 2022555917
Nov 2022545420
Dec 2022454725
Jan 2023465019
Feb 2023606113
Mar 2023293235
Apr 2023373719
May 2023454511
Jun 202326269
Jul 2023343519
Aug 2023323213
Sep 2023313320
Oct 2023404018
Nov 2023545624
Dec 2023404114
Jan 202429306
Feb 2024333316
Mar 2024494960
Apr 2024505126
May 2024292922
Jun 2024444532
Jul 2024373717
Aug 20243940170
Sep 2024343517
Oct 2024222218
Nov 2024333516
Dec 202410710719
Jan 2025596232
Feb 2025494931
Mar 2025354027
Apr 2025424417
May 2025343616
Jun 2025181813
Total293330001409